APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunohistochemistry

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Immunohistochemistry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025180 pages

Choose your research edition.

Industry ResearchImmunohistochemistry Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunohistochemistry Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Immunohistochemistry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunohistochemistry Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunohistochemistry Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Immunohistochemistry market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Immunohistochemistry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunohistochemistry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunohistochemistry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immunohistochemistry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunohistochemistry include Thermo Fisher Scientific Inc., PerkinElmer, Inc., Merck Millipore, F. Hoffmann-La Roche Ltd, Danaher, Cell Signaling Technology, Inc., BioSB, Agilent Technologies, Inc. and Abcam plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immunohistochemistry market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunohistochemistry and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunohistochemistry sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunohistochemistry market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunohistochemistry Segment by Company

Thermo Fisher Scientific Inc.

PerkinElmer, Inc.

Merck Millipore

F. Hoffmann-La Roche Ltd

Danaher

Cell Signaling Technology, Inc.

BioSB

Agilent Technologies, Inc.

Abcam plc

Immunohistochemistry Segment by Type

Kits

Reagents

Equipment

Antibodies

Immunohistochemistry Segment by Application

Diagnostics

Drug Testing

Immunohistochemistry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunohistochemistry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunohistochemistry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunohistochemistry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunohistochemistry market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunohistochemistry manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Immunohistochemistry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Immunohistochemistry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Immunohistochemistry Industry Trends Table 2. Immunohistochemistry Industry Drivers Table 3. Immunohistochemistry Industry Opportunities and Challenges Table 4. Immunohistochemistry Industry Restraints Table 5. Global Immunohistochemistry Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Immunohistochemistry Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Immunohistochemistry Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Immunohistochemistry Sales Market Share by Manufacturers Table 9. Global Immunohistochemistry Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Immunohistochemistry Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Immunohistochemistry Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Immunohistochemistry Manufacturers, Product Type & Application Table 13. Global Immunohistochemistry Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunohistochemistry by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Kits Table 17. Major Manufacturers of Reagents Table 18. Major Manufacturers of Equipment Table 19. Major Manufacturers of Antibodies Table 20. Global Immunohistochemistry Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Immunohistochemistry Sales by Type (2021-2026) & (k units) Table 22. Global Immunohistochemistry Sales by Type (2027-2032) & (k units) Table 23. Global Immunohistochemistry Sales Market Share by Type (2021-2026) Table 24. Global Immunohistochemistry Sales Market Share by Type (2027-2032) Table 25. Global Immunohistochemistry Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Immunohistochemistry Revenue by Type (2021-2026) & (k units) Table 27. Global Immunohistochemistry Revenue by Type (2027-2032) & (k units) Table 28. Global Immunohistochemistry Revenue Market Share by Type (2021-2026) Table 29. Global Immunohistochemistry Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Diagnostics Table 31. Major Manufacturers of Drug Testing Table 32. Global Immunohistochemistry Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Immunohistochemistry Sales by Application (2021-2026) & (k units) Table 34. Global Immunohistochemistry Sales by Application (2027-2032) & (k units) Table 35. Global Immunohistochemistry Sales Market Share by Application (2021-2026) Table 36. Global Immunohistochemistry Sales Market Share by Application (2027-2032) Table 37. Global Immunohistochemistry Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Immunohistochemistry Revenue by Application (2021-2026) & (k units) Table 39. Global Immunohistochemistry Revenue by Application (2027-2032) & (k units) Table 40. Global Immunohistochemistry Revenue Market Share by Application (2021-2026) Table 41. Global Immunohistochemistry Revenue Market Share by Application (2027-2032) Table 42. Global Immunohistochemistry Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Immunohistochemistry Sales by Region (2021-2026) & (k units) Table 44. Global Immunohistochemistry Sales Market Share by Region (2021-2026) Table 45. Global Immunohistochemistry Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Immunohistochemistry Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Immunohistochemistry Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Immunohistochemistry Sales by Country (2021-2026) & (k units) Table 49. North America Immunohistochemistry Sales by Country (2027-2032) & (k units) Table 50. Europe Immunohistochemistry Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Immunohistochemistry Sales by Country (2021-2026) & (k units) Table 52. Europe Immunohistochemistry Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Immunohistochemistry Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Immunohistochemistry Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Immunohistochemistry Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Immunohistochemistry Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Immunohistochemistry Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Immunohistochemistry Sales by Country (2027-2032) & (k units) Table 59. Global Immunohistochemistry Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Immunohistochemistry Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Immunohistochemistry Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Immunohistochemistry Revenue Market Share by Region (2021-2026) Table 63. Global Immunohistochemistry Revenue Market Share by Region (2027-2032) Table 64. Thermo Fisher Scientific Inc. Company Information Table 65. Thermo Fisher Scientific Inc. Business Overview Table 66. Thermo Fisher Scientific Inc. Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Thermo Fisher Scientific Inc. Immunohistochemistry Product Portfolio Table 68. Thermo Fisher Scientific Inc. Recent Development Table 69. PerkinElmer, Inc. Company Information Table 70. PerkinElmer, Inc. Business Overview Table 71. PerkinElmer, Inc. Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. PerkinElmer, Inc. Immunohistochemistry Product Portfolio Table 73. PerkinElmer, Inc. Recent Development Table 74. Merck Millipore Company Information Table 75. Merck Millipore Business Overview Table 76. Merck Millipore Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck Millipore Immunohistochemistry Product Portfolio Table 78. Merck Millipore Recent Development Table 79. F. Hoffmann-La Roche Ltd Company Information Table 80. F. Hoffmann-La Roche Ltd Business Overview Table 81. F. Hoffmann-La Roche Ltd Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. F. Hoffmann-La Roche Ltd Immunohistochemistry Product Portfolio Table 83. F. Hoffmann-La Roche Ltd Recent Development Table 84. Danaher Company Information Table 85. Danaher Business Overview Table 86. Danaher Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Danaher Immunohistochemistry Product Portfolio Table 88. Danaher Recent Development Table 89. Cell Signaling Technology, Inc. Company Information Table 90. Cell Signaling Technology, Inc. Business Overview Table 91. Cell Signaling Technology, Inc. Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Cell Signaling Technology, Inc. Immunohistochemistry Product Portfolio Table 93. Cell Signaling Technology, Inc. Recent Development Table 94. BioSB Company Information Table 95. BioSB Business Overview Table 96. BioSB Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. BioSB Immunohistochemistry Product Portfolio Table 98. BioSB Recent Development Table 99. Agilent Technologies, Inc. Company Information Table 100. Agilent Technologies, Inc. Business Overview Table 101. Agilent Technologies, Inc. Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Agilent Technologies, Inc. Immunohistochemistry Product Portfolio Table 103. Agilent Technologies, Inc. Recent Development Table 104. Abcam plc Company Information Table 105. Abcam plc Business Overview Table 106. Abcam plc Immunohistochemistry Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Abcam plc Immunohistochemistry Product Portfolio Table 108. Abcam plc Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Immunohistochemistry Distributors List Table 112. Immunohistochemistry Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Immunohistochemistry Product Image Figure 2. Global Immunohistochemistry Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunohistochemistry Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunohistochemistry Sales (2021-2032) & (k units) Figure 5. Global Immunohistochemistry Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Immunohistochemistry Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Kits Image Figure 9. Reagents Image Figure 10. Equipment Image Figure 11. Antibodies Image Figure 12. Global Immunohistochemistry Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Immunohistochemistry Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Immunohistochemistry Sales Market Share by Type (2021-2032) Figure 15. Global Immunohistochemistry Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Immunohistochemistry Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Immunohistochemistry Revenue Market Share by Type (2021-2032) Figure 18. Diagnostics Image Figure 19. Drug Testing Image Figure 20. Global Immunohistochemistry Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Immunohistochemistry Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Immunohistochemistry Sales Market Share by Application (2021-2032) Figure 23. Global Immunohistochemistry Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Immunohistochemistry Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Immunohistochemistry Revenue Market Share by Application (2021-2032) Figure 26. North America Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Immunohistochemistry Sales Market Share by Country (2021-2032) Figure 28. U.S. Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Immunohistochemistry Sales Market Share by Country (2021-2032) Figure 33. Germany Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Immunohistochemistry Sales Market Share by Country (2021-2032) Figure 40. China Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Immunohistochemistry Sales Market Share by Country (2021-2032) Figure 48. Brazil Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Immunohistochemistry Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Immunohistochemistry Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Immunohistochemistry Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Immunohistochemistry Revenue (2021-2032) & (US$ Million) Figure 59. North America Immunohistochemistry Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Immunohistochemistry Revenue (2021-2032) & (US$ Million) Figure 61. Europe Immunohistochemistry Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Immunohistochemistry Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Immunohistochemistry Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Immunohistochemistry Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Immunohistochemistry Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Immunohistochemistry Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Immunohistochemistry Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Kits
  • Reagents
  • Equipment
  • Antibodies
Applications
  • Diagnostics
  • Drug Testing
Companies covered
  • Thermo Fisher Scientific Inc.
  • PerkinElmer, Inc.
  • Merck Millipore
  • F. Hoffmann-La Roche Ltd
  • Danaher
  • Cell Signaling Technology, Inc.
  • BioSB
  • Agilent Technologies, Inc.
  • Abcam plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immunohistochemistry Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immunohistochemistry Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Immunohistochemistry Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Immunohistochemistry Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Immunohistochemistry Market Dynamics
  1. 2.1 Immunohistochemistry Industry Trends
  2. 2.2 Immunohistochemistry Industry Drivers
  3. 2.3 Immunohistochemistry Industry Opportunities and Challenges
  4. 2.4 Immunohistochemistry Industry Restraints
3 Immunohistochemistry Market by Manufacturers
  1. 3.1 Global Immunohistochemistry Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Immunohistochemistry Sales by Manufacturers (2021-2026)
  3. 3.3 Global Immunohistochemistry Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Immunohistochemistry Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunohistochemistry Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Immunohistochemistry Manufacturers, Product Type & Application
  7. 3.7 Global Immunohistochemistry Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunohistochemistry Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunohistochemistry Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunohistochemistry Tier 1, Tier 2, and Tier 3
4 Immunohistochemistry Market by Type
  1. 4.1 Immunohistochemistry Type Introduction
  2. 4.1.1 Kits
  3. 4.1.2 Reagents
  4. 4.1.3 Equipment
  5. 4.1.4 Antibodies
  6. 4.2 Global Immunohistochemistry Sales by Type
  7. 4.2.1 Global Immunohistochemistry Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Immunohistochemistry Sales by Type (2021-2032)
  9. 4.2.3 Global Immunohistochemistry Sales Market Share by Type (2021-2032)
  10. 4.3 Global Immunohistochemistry Revenue by Type
  11. 4.3.1 Global Immunohistochemistry Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Immunohistochemistry Revenue by Type (2021-2032)
  13. 4.3.3 Global Immunohistochemistry Revenue Market Share by Type (2021-2032)
5 Immunohistochemistry Market by Application
  1. 5.1 Immunohistochemistry Application Introduction
  2. 5.1.1 Diagnostics
  3. 5.1.2 Drug Testing
  4. 5.2 Global Immunohistochemistry Sales by Application
  5. 5.2.1 Global Immunohistochemistry Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Immunohistochemistry Sales by Application (2021-2032)
  7. 5.2.3 Global Immunohistochemistry Sales Market Share by Application (2021-2032)
  8. 5.3 Global Immunohistochemistry Revenue by Application
  9. 5.3.1 Global Immunohistochemistry Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Immunohistochemistry Revenue by Application (2021-2032)
  11. 5.3.3 Global Immunohistochemistry Revenue Market Share by Application (2021-2032)
6 Global Immunohistochemistry Sales by Region
  1. 6.1 Global Immunohistochemistry Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunohistochemistry Sales by Region (2021-2032)
  3. 6.2.1 Global Immunohistochemistry Sales by Region (2021-2026)
  4. 6.2.2 Global Immunohistochemistry Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immunohistochemistry Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Immunohistochemistry Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Immunohistochemistry Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Immunohistochemistry Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Immunohistochemistry Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Immunohistochemistry Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Immunohistochemistry Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Immunohistochemistry Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Immunohistochemistry Revenue by Region
  1. 7.1 Global Immunohistochemistry Revenue by Region
  2. 7.1.1 Global Immunohistochemistry Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Immunohistochemistry Revenue by Region (2021-2026)
  4. 7.1.3 Global Immunohistochemistry Revenue by Region (2027-2032)
  5. 7.1.4 Global Immunohistochemistry Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Immunohistochemistry Revenue (2021-2032)
  8. 7.2.2 North America Immunohistochemistry Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Immunohistochemistry Revenue (2021-2032)
  11. 7.3.2 Europe Immunohistochemistry Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Immunohistochemistry Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Immunohistochemistry Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Immunohistochemistry Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Immunohistochemistry Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific Inc.
  2. 8.1.1 Thermo Fisher Scientific Inc. Company Information
  3. 8.1.2 Thermo Fisher Scientific Inc. Business Overview
  4. 8.1.3 Thermo Fisher Scientific Inc. Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Inc. Immunohistochemistry Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Inc. Recent Developments
  7. 8.2 PerkinElmer, Inc.
  8. 8.2.1 PerkinElmer, Inc. Company Information
  9. 8.2.2 PerkinElmer, Inc. Business Overview
  10. 8.2.3 PerkinElmer, Inc. Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PerkinElmer, Inc. Immunohistochemistry Product Portfolio
  12. 8.2.5 PerkinElmer, Inc. Recent Developments
  13. 8.3 Merck Millipore
  14. 8.3.1 Merck Millipore Company Information
  15. 8.3.2 Merck Millipore Business Overview
  16. 8.3.3 Merck Millipore Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Millipore Immunohistochemistry Product Portfolio
  18. 8.3.5 Merck Millipore Recent Developments
  19. 8.4 F. Hoffmann-La Roche Ltd
  20. 8.4.1 F. Hoffmann-La Roche Ltd Company Information
  21. 8.4.2 F. Hoffmann-La Roche Ltd Business Overview
  22. 8.4.3 F. Hoffmann-La Roche Ltd Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 F. Hoffmann-La Roche Ltd Immunohistochemistry Product Portfolio
  24. 8.4.5 F. Hoffmann-La Roche Ltd Recent Developments
  25. 8.5 Danaher
  26. 8.5.1 Danaher Company Information
  27. 8.5.2 Danaher Business Overview
  28. 8.5.3 Danaher Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Danaher Immunohistochemistry Product Portfolio
  30. 8.5.5 Danaher Recent Developments
  31. 8.6 Cell Signaling Technology, Inc.
  32. 8.6.1 Cell Signaling Technology, Inc. Company Information
  33. 8.6.2 Cell Signaling Technology, Inc. Business Overview
  34. 8.6.3 Cell Signaling Technology, Inc. Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cell Signaling Technology, Inc. Immunohistochemistry Product Portfolio
  36. 8.6.5 Cell Signaling Technology, Inc. Recent Developments
  37. 8.7 BioSB
  38. 8.7.1 BioSB Company Information
  39. 8.7.2 BioSB Business Overview
  40. 8.7.3 BioSB Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BioSB Immunohistochemistry Product Portfolio
  42. 8.7.5 BioSB Recent Developments
  43. 8.8 Agilent Technologies, Inc.
  44. 8.8.1 Agilent Technologies, Inc. Company Information
  45. 8.8.2 Agilent Technologies, Inc. Business Overview
  46. 8.8.3 Agilent Technologies, Inc. Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Agilent Technologies, Inc. Immunohistochemistry Product Portfolio
  48. 8.8.5 Agilent Technologies, Inc. Recent Developments
  49. 8.9 Abcam plc
  50. 8.9.1 Abcam plc Company Information
  51. 8.9.2 Abcam plc Business Overview
  52. 8.9.3 Abcam plc Immunohistochemistry Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Abcam plc Immunohistochemistry Product Portfolio
  54. 8.9.5 Abcam plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunohistochemistry Value Chain Analysis
  2. 9.1.1 Immunohistochemistry Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunohistochemistry Production Mode & Process
  6. 9.2 Immunohistochemistry Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunohistochemistry Distributors
  9. 9.2.3 Immunohistochemistry Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst